Articles
July 21, 2015
Exclusion of Patentee's Damages Expert Not Sufficient to Justify Granting Summary Judgment
Fish & Richardson
July 21, 2015
Claims Should Be Broadly Construed to Include Their Full Plain Meaning Where There Is No Disclaimer or Lexicography
Fish & Richardson
July 10, 2015
NDCA bars negative NPE terminology; allows product revenue and settlement agreements
Fish & Richardson
July 08, 2015
Software Claim Addressing Concepts Long Known in Other Fields and Lacking Other Inventive Concept Is Not Patent Eligible
Fish & Richardson
July 07, 2015
FDA's Latest ANDA Guidance: Patent Carve Outs Become a Guessing Game
Pharmaceutical Compliance Monitor
July 03, 2015
DDE excludes revenues & profits due to failed apportionment, allows do-over
Fish & Richardson
July 01, 2015
Utah court allows evidence of minimum royalty payments by third parties
Fish & Richardson
June 19, 2015
CDIL rejects defendants' EMVR and SSPPU arguments and allows royalty base on entire products
Fish & Richardson
June 18, 2015
Ordered Method Claim Does Not Bar Partly-Simultaneous Performance of Steps
Fish & Richardson
June 17, 2015
Claims Covering Basic Detection of Naturally-Occurring Compound, However Scientifically Significant, Not Patent Eligible
Fish & Richardson
IP Law Essentials
-
What is the first step in the patent litigation process? What's a Markman hearing? Can you be sued at the International Trade Commission? Our IP Law Essentials series answers these questions and many more, providing a thorough introduction to IP law from some of the world's premier IP practitioners.